Save the date!
Free biobanking conference!
“Improving biobank standards- local and global perspectives”
Tuesday 12th June, 10am to 5pm
Kerry Packer Auditorium, Royal Prince Alfred Hospital Campus, Camperdown, Sydney (View Map)
Opening address: Dr Kerry Chant (NSW Chief Health Officer)
Professor Peter Watson (Vancouver, Canada)
Professor Sunil Lakhani (University of Queensland)
Professor Jennifer Byrne (Kids Research Institute)
Professor Christine Clarke (Westmead Institute for Medical Research)
Professor Ian Kerridge (University of Sydney)
Dr Tony Penna (NSW Office for Health and Medical Research)
A/Prof Kevin Spring (Ingham Institute for Applied Medical Research)
Full programme with additional speakers will be available shortly
Registration via Eventbrite
Please register, as places are limited, and catering will be supplied.
Supported by Cancer Institute NSW
For all enquiries please call Ms Bharvi Maneck on (02) 9845 1213 or respond via email.
We look forward to sharing the conference with you.
We will shortly commence face to face education sessions across 7 sites in NSW:
The University of Sydney
Please look out for an email, advising you of the dates that we will be visiting your site!
Please contact Amanda Rush or Candace Carter for further information.
NSW Health Pathology launched their Biobank Certification Program on 8th June 2016. This program is based on the successful Canadian CTRNet program, and provides comprehensive education modules for biobank staff, as well as document templates and policies/procedures for all aspects of biobanking.
It is relevant to all biobank types, and can be scaled to suit both smaller biobank who provide biospecimens to local researchers, and large biobanks with international sample provision.
Please visit the biobank certification website for further information on this important program.
Information sessions are being held on the 8th June 2016 to inform the biobanking community about the soon to be launched NSW Biobank Certification Scheme.
Representatives from the Canadian Certification program, on which the NSW Scheme is based, will be on hand to describe the scheme and answer questions from their experiences in Canada.
NSW Health Pathology will describe how the system will work in NSW and biobanks will be able to register to the program.
Two duplicate sessions are being held:
a) 9:30am to 12:00pm
b) 1:30pm to 4:00pm
Morning/afternoon tea will be provided; registration is essential.
To register, or for further information, please contact
Candace Carter, Project Officer, Biobanking Services, NSW Health Pathology.
The annual meeting for the Australasian Biospecimen Network Association (ABNA) shall be held on 26th and 27th October 2015 at the Crowne Plaza, Coogee Beach. The theme of this year’s conference is ‘Sustainable Biobanking in the Face of Change’, which will bring together experts in sustainability, change management and the implementation of practice into policy (and vice versa) as well as leaders from within the biobanking community to pose the challenging questions that must be addressed if biobanks are to find the most strategic pathways that see them sustainably and meaningfully exist within the Australasian biomedical research landscape long into the future.
Further information can be found by visiting the ABNA website.
We are pleased to announce the completion of the 2013/14 Biobanking Stakeholder Network project, “Pre-operative consent”. This Cancer Institute NSW-funded project was conducted across four Translational Cancer Research Centres and in eight NSW hospitals*, with the aim of embedding biobanking consent into routine perioperative workflows. In doing so, we sought to better engage hospital staff and increase tissue and data collection from eligible patients.
The project team worked collaboratively to develop a suite of project materials, including patient consent forms and brochures, and promotional and educational materials that supported stakeholder engagement initiatives at hospital sites. The rollout of the consent projects is complete at five sites, with the remaining sites in progress at the time of writing. Two key outcome measures were assessed:
- The rate of request for consent (the number of patients who were asked to consent to participate as a proportion of the total number of operations for a malignancy)
- The participation rate (the proportion of those patients asked to participate in the biobank who actually agreed).
Participation rates were very high: 99% of patients across all sites who were asked to participate agreed to have their specimens banked and their health data collected.
Rate of request for consent was satisfactory, but significant opportunities for improvement were identified and are under active consideration.
The following aspects had a significant impact on both the participation and request for consent rates for this project:
- The integration of biobanking consent processes into routine hospital workflows
- The inclusion of biobanking consent forms in existing hospital documentation
- The mapping of patient pathways in participating hospital departments to inform when and where consent should be offered
- The identification of project champions to promote staff engagement
- The development of ongoing educational activities to keep biobanking initiatives visible to clinical staff.
* Participating organisations TCRCs: Hunter Cancer Research Alliance, Translational Cancer Research Network, Sydney Vital and Sydney Catalyst Hospitals: John Hunter and Calvary Mater Hospitals, Newcastle; Royal Hospital for Women, Chris O’Brien Lifehouse, Prince of Wales, St George, Royal North Shore and Royal Prince Alfred Hospitals, Sydney
If you are interested in a copy of this report, please click here.
Suggested citation: Meagher N (ed). ‘The Biobanking Stakeholders Network Pre-operative Consent Project 2013-2014’. CINSW BSN, March 2015.
We are pleased to announce the submission of A/Prof Kevin Spring’s 2013/14 Biobanking Stakeholder Network project, “Data Management Systems and Practices of the Cancer Institute NSW Biobanking Stakeholder Network” report. The Cancer Institute NSW funded three survey-based projects in 2013/14, which together were tasked with gaining an in-depth understanding of the practices and systems across BSN biobanks, via a comprehensive combined survey.
This report includes comprehensive data management information on all 23 operational cancer biobanks in NSW, and specifically aimed to:
- Determine what biobanking data management systems are in use across the BSN, and how these are used for data collection, storage and management.
- Identify the current levels of harmonisation in biobanking data management systems and data collection/management practices across the BSN.
- Identify minimal IT standards and identify gaps in the application of these and approaches that could address this.
- Compare and contrast the data fields held by BSN biobanks with the Cancer Australia biospecimen minimal data set, and identify IT approaches that could address any imbalance.
- Determine the interoperability of the current systems in use and if there is scope for any integration of data sets for the common good.
- Map the financial and workforce support of BSN biobank data management systems and determine the costs and benefits of implementing more centralised IT/data management approaches and the steps required to implement these.
If you would like a copy of this report, please click here.
Christiansen, J.H., Farrell, J.P. and Spring, K.J. ‘Data Management Systems and Practices of the Cancer Institute NSW Biobanking Stakeholder Network’. Sydney. CONCERT Translational Cancer Research Centre. December 2014.
Organisation of this Biobanking Stakeholder Network symposium formed part of the 2014/15 BSN project “Improving Biospecimen Quality within BSN Biobanks”. The symposium was jointly hosted by the Cancer Institute NSW and The University of Sydney for BSN member biobank staff and other interested stakeholders.
The symposium was held on Friday 22nd May, 2015, at the Darlington Centre Conference Room, 174 City Rd, Darlington, The University of Sydney.
It was divided into two sections, with a morning session (Part 1) featuring presentations on ‘Positioning biobanking to meet the 21st century’ and a late morning/afternoon session (Part 2) on biospecimen quality, from the perspective of biobanks and researchers. The day commenced with presentations from the Office for Health and Medical Research, and NSW Health Pathology, followed by Professor Sanchia Aranda, Acting CEO of Cancer Institute NSW. The remainder of the day featured presentations on the three main areas of BSN research, namely patient consent, data linkage, and operations standardisation, and presentations on biospecimen quality from both a biobank and researcher perspective.
The conference program, found here, showcased a day of biobanking presentations, discussions and networking. Presentations from the day have been posted in the resources section of the website.
If you would like more information on this BSN biobanking conference, please email Amanda Rush using details on the contacts page.